Literature DB >> 23054127

Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation.

Andrew C T Ha1, Paul Dorian.   

Abstract

Improvement of symptoms and health-related quality of life (HRQoL) are important treatment goals in the management of patients with atrial fibrillation (AF). For patients with symptomatic AF, catheter ablation is a commonly performed therapy for rhythm control. As a result, accurate documentation of the changes in HRQoL for these patients is necessary. This paper will review why HRQoL questionnaires are important in evaluating patient outcomes for AF ablation. First, we discuss how the results of these questionnaires can influence the cost-effectiveness of AF ablation. This may, in turn, affect healthcare resource allocation in favor of this therapy. Also, these questionnaires can provide additional information over traditional quantitative measures of AF burden in assessing post-ablation outcomes. By standardizing the way by which HRQoL is measured and reported, these questionnaires are valuable in evaluating this important patient-reported outcome in AF ablation trials.

Entities:  

Mesh:

Year:  2012        PMID: 23054127     DOI: 10.1007/s10840-012-9721-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  26 in total

1.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.

Authors:  Gaetano Senatore; Giuseppe Stabile; Emanuele Bertaglia; Giovanni Donnici; Antonio De Simone; Franco Zoppo; Pietro Turco; Pietro Pascotto; Massimo Fazzari
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Louise S Jenkins; Michael Brodsky; Eleanor Schron; Mina Chung; Thomas Rocco; Ellis Lader; Martha Constantine; Robert Sheppard; Donald Holmes; Donna Mateski; Liz Floden; Marilyn Prasun; H Leon Greene; Lynn Shemanski
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

5.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

6.  Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation.

Authors:  Christopher Piorkowski; Hans Kottkamp; Hildegard Tanner; Richard Kobza; Jens Cosedis Nielsen; Arash Arya; Gerhard Hindricks
Journal:  J Cardiovasc Electrophysiol       Date:  2005-12

7.  Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.

Authors:  Joseph A Ladapo; Guy David; Candace L Gunnarsson; Steven C Hao; Sarah A White; Jamie L March; Matthew R Reynolds
Journal:  J Cardiovasc Electrophysiol       Date:  2011-07-21

8.  Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective.

Authors:  Won Chan Lee; Gervasio A Lamas; Sanjeev Balu; James Spalding; Qin Wang; Chris L Pashos
Journal:  J Med Econ       Date:  2008       Impact factor: 2.448

9.  Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life.

Authors:  Jacob Pontoppidan; Jens Cosedis Nielsen; Steen Hvitfeldt Poulsen; Peter Steen Hansen
Journal:  Pacing Clin Electrophysiol       Date:  2009-06       Impact factor: 1.976

Review 10.  Quality of life in atrial fibrillation: measurement tools and impact of interventions.

Authors:  Matthew R Reynolds; Ethan Ellis; Peter Zimetbaum
Journal:  J Cardiovasc Electrophysiol       Date:  2008-02-05
View more
  2 in total

1.  Introduction: health policy II. A new era of heath policy in electrophysiology and cardiology.

Authors:  Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2016-09-16       Impact factor: 1.900

2.  Symptoms and health-related quality of life 5 years after catheter ablation of atrial fibrillation.

Authors:  Ulla Walfridsson; Anders Hassel Jönsson; Lars O Karlsson; Ioan Liuba; Henrik Almroth; Emma Sandgren; Håkan Walfridsson; Emmanouil Charitakis
Journal:  Clin Cardiol       Date:  2021-12-16       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.